KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Payables (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Payables for 17 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Payables rose 14.78% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 14.78% year-over-year, with the annual reading at $1.6 billion for FY2025, 14.78% up from the prior year.
  • Payables hit $1.6 billion in Q4 2025 for Quest Diagnostics, up from $1.5 billion in the prior quarter.
  • In the past five years, Payables ranged from a high of $1.6 billion in Q3 2021 to a low of $1.2 billion in Q3 2023.
  • Historically, Payables has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2022.
  • Biggest five-year swings in Payables: soared 58.92% in 2021 and later decreased 22.41% in 2023.
  • Year by year, Payables stood at $1.6 billion in 2021, then dropped by 12.75% to $1.4 billion in 2022, then fell by 2.65% to $1.4 billion in 2023, then grew by 2.58% to $1.4 billion in 2024, then increased by 14.78% to $1.6 billion in 2025.
  • Business Quant data shows Payables for DGX at $1.6 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.3 billion in Q2 2025.